attr-cm management: pearls from recent clinical trials and tailoring therapy
Published 4 months ago • 27 plays • Length 13:30Download video MP4
Download video MP3
Similar videos
-
21:56
clinical pearls for the accurate diagnosis and optimal treatment of hereditary attr amyloidosis
-
59:53
recent advances in attr cm therapy - webinar - 26 sep
-
13:30
treating attr-cm with a novel therapeutic approach: understanding the attributes to success
-
8:01
potential reversibility of attr-cm through anti-attr amyloid antibodies
-
0:31
recognize the signs of attr-cm
-
12:22
people, places, and things: key resources for attr-cm nurse navigators
-
0:50
the impact of acoramidis on clinical outcomes in attr-cm
-
2:43
acoramidis treatment is effective in patients with attr-cm
-
6:00
beyond the horizon: helios clinical trials in attr cardiomyopathy
-
18:48
transthyretin amyloid cardiomyopathy (attr-cm) visiting vignette
-
3:51
current diagnostic and management strategies for attr amyloidosis
-
1:07:51
hfsa 2023 cme symposium - transthyretin amyloid cardiomyopathy attr-cm
-
28:56
ep 1 : the clock is ticking on attr-cm
-
0:40
attr cm resolution | #shorts #hearttreatment #medicalinnovation
-
58:58
emerging strategies in the management of attr amyloidosis
-
16:33
transthyretin amyloid and new treatment options
-
3:33
how biomarkers such as nt-proβnp-1 help define progression in attr-cm
-
13:01
newly fda approved amvuttra™ for treatment of hattr amyloidosis with polyneuropathy
-
1:13
an overview of current and future clinical trials in amyloidosis